Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01528072 · ClinicalTrials.gov registry record · NA
Dynesys Spinal System Post Market 522 Study
A NA study, sponsored by Zimmer Biomet.
- Terminated
- Registry status
- NA
- Development phase
- 153
- Enrollment target
NCT01528072 is a NA study that was terminated before completion, run by Zimmer Biomet. The registered enrollment target is 153 participants.
The verdict
NCT01528072, a NA study, was terminated before completion, sponsored by Zimmer Biomet.
- TERMINATED
- Registry status
- NA
- Development phase
- 153 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the safety and fusion rates following posterior lateral fusion with the Dynesys Spinal System used as an adjunct to fusion and compare to literature control.
Interventions
- DEVICE Dynesys Spinal System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 153 participants |
| Start Date | 2012-03 |
| Est. Completion | 2017-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01528072
The ClinicalTrials.gov registry entry for NCT01528072 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 153 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dynesys Spinal System is the first listed.
NCT01528072 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01528072 about?
NCT01528072 is a clinical study titled "Dynesys Spinal System Post Market 522 Study". The purpose of this study is to assess the safety and fusion rates following posterior lateral fusion with the Dynesys Spinal System used as an adjunct to fusion and compare to literature control.
What is the current status of trial NCT01528072?
This trial is currently terminated. It is a NA study. The enrollment target is 153 participants. The study started on 2012-03. Estimated completion is 2017-04.
What interventions are being tested in trial NCT01528072?
The interventions under investigation include: Dynesys Spinal System (DEVICE).
Who is sponsoring clinical trial NCT01528072?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.